Showing 6 results for Progesterone
Mohammad Reza Palizvan, Hajar Rajabian, Elahe Mirzazadeh, Yahya Jand, Ehsan Alah Ghaznavi Rad,
Volume 11, Issue 4 (12-2008)
Abstract
Background: Although the roles of steroid hormones in the activation and maintenance of reproductive function are proved well, emerging evidence indicated that these steroids influence on performance of learning and memory. These effects are complex and vary with task, gender, and age, as well as the regimens of steroid exposure. This study was carried out in order to assess the role of progesterone administration in newborns rats on Morris water maze learning ability after adolescence.
Methods and Materials : This experimental study was carried out on 36 newborns Wistar rats. Rats were divided randomly into 6 groups female progesterone, male progesterone, female sesamoide, male sesamoid rats and male and female control rats. Progesterone groups were treated with a single injection of progesterone (100 mg/kg) and sesamoid groups were received the same volume of sesamoid oil as the progesterone vehicle in day 1 or 2 after brith, 60 days later, spatial memory ability was determined in Morris water maze.
Results : The results of this study show that water maze learning can enhance by administration of sesamoid oil in newborn female pups in compared to progesterone and control groups (p<0.05). In addition, adding progesterone to sesame oil reduce water maze learning to control level.
Conclusion: The hypothesis that progesterone impaired spatial reference memory in female rats was supported by this experiment.
Shabanali Alizadeh, Kamran Moshfeghi, Mssoumeh Kalantari, Khadijeh Ebrahimi,
Volume 12, Issue 4 (2-2010)
Abstract
Background: The existence of estrogen and progesterone receptors, p53, human epidermal receptor-2(HER-2) and cathepsin-D are among the prognostic markers for breast cancer. In this study, we investigated the relationship between these factors and lymph-node involvement. Materials and Methods: In this case-control analytic study, 105 patients with breast cancer were investigated. After detecting breast mass, surgical biopsy was done and the status of the estrogen and progesterone receptors, p53, HER-2, and cathepsin-D were studied. Collected data were registered in a checklist and were subjected to analysis. Results: There was no relationship between lymph-node involvement and estrogen and progesterone receptors, p53, cathepsin-D and HER-2. Conclusion: In order to get more precise results about hormonal receptors, p53, HER-2 and cathespin-D, a similar research with a larger sample size over a longer period of time is needed.
Lotfollah Khajehpour, Hosein Najafzadeh Varzi , Mahnaz Kesmati, Fahimeh Hasanvand,
Volume 16, Issue 2 (5-2013)
Abstract
Background: Progesterone is a female steroid hormone that has a potent anticonvulsant effect on human and animal. The aim of this study was to investigate the involvement of opioid receptors in the anticonvulsant effect of progesterone on ovariectomized mice.
Materials and Methods: In this experimental study, all animals were ovariectomized. After two weeks, they received an intraperitoneal (i.p.) injection of drugs (progesterone and naloxone) or saline. The animals also received a subcutaneous injection of strychnine for induction of convulsive seizures, 30 minutes after administration of drugs or saline. For evaluation of convulsion in the animals, convulsion onset time, convulsion duration, the number of seizures, and death time were recorded.
Results: Progesterone (25 and 50 mg/kg, i.p.) decreased the strychnine-induced convulsion. The anticonvulsant effect of 50 mg/kg of progesterone was abolished by naloxone (5 mg/kg, i.p.) injection, whereas administration of the same doses of naloxone alone did not affect strychnine-induced convulsion.
Conclusion: These results suggest that opioid receptors may play an important role in the anticonvulsant effect of progesterone.
Eslam Zabihi, Seyed Eghbal Motavallibashi, Khayam Bamdad, Faegheh Pilevaribadi, Hamid Sheikhkanloui Milan,
Volume 20, Issue 3 (6-2017)
Abstract
Abstract
Background: The multiple sclerosis is a chronic disease of the central nervous system. Since the level of sex hormone and multiple sclerosis (MS) disease affects one another, the aim of this study was to evaluate the impact of the hydroalcoholic extract of truffle on the hormone levels of estrogen and progesterone administered in experimental model of MS-induced rats.
Materials and Methods: In this experimental study, 42 Wistar female rats, weighing 180±10 grams selected into 6 groups each consisting of 7 rats. Normal control didn’t receive any treatment and experimental group was given Cuprizone toxin (as a MS model inducer) for 40 days. The experimental groups (2, 3, 4 and 5) in addition to Cuprizone received the normal saline, 110, 220 and 330 mg/kg/0.2ml (i.p.) of Hydroalcoholic extract of truffle for 12 days too. Blood samples were taken at the end of the twelfth day from all groups involved and levels of sex hormones were measured.
Results: Cuprizone decreases estrogen, progesterone levels and also causes weight loss, while injection of hydroalcoholic extract of truffle increased serum levels of estrogen (in experimental group 4) and progesterone (in experimental group 4 & 5) compared to MS-induced group.
Conclusion: Results of the study revealed that the hydroalcoholic extract of truffle (at dosages of 220 and 330 mg/kg) could increase estrogen and progesterone levels in rats experienced experimental multiple sclerosis.
Majid Amiri Motlagh, Mohammad Ali Atlasi, Zeinab Vahidinia, Sayyed Alireza Talaei, Zeinab Rezazadeh Lavaf, Abolfazl Azami Tameh,
Volume 20, Issue 5 (8-2017)
Abstract
Abstract
Background: Glutamate is the most widespread excitatory neurotransmitter in the mammalian central nervous system (CNS) and plays major role in the pathogenesis of ischemia brain injury.Glutamate transporters have a major role in glutamate removal and maintain its concentration below excitotoxic levels. Although estrogen’s and progesterone’s neuroprotective effects were well-described, the exact molecular mechanism has yet to be determined. This study has investigated estrogen and progesterone effect on glutamate transporters expression in the ischemic penumbra/peri-infarct region in rat.
Materials and Methods: Adult male Wistar rats were subjected to transient middle cerebral artery occlusion (tMCAO) for 1 h. Estrogen and progesterone combination was immediately injected after tMCAO subcutaneously. Sensorimotor functional tests for evaluating behavioral deficits and TTC staining for measurement of infarct volume were performed 24 h after MCAO. Real-time PCR technique was used for gene expression analysis of glutamate transporters EAAT2 and EAAT3.
Results: The combination of estrogen and progesterone could significantly reduce lesion volume. Also, hormone therapy could improve ischemic neurological disorders. After hormone therapy, gene expression of glutamate transporters EAAT2 and EAAT3 did not show significant changes.
Conclusion: Combined estrogen–progesterone treatment significantly reduces neurological deficits and infarct volume; these effects are independent of the glutamate transporters signaling pathways.
Neda Kafi, Amene Barjaste Yazdi, Rambod Khajei, Mohammadreza Hoseinabadi,
Volume 26, Issue 2 (7-2023)
Abstract
Introduction: The purpose of this research was to investigate the effect of a period of resistance training and melatonin consumption on sex hormone levels, pain intensity, and sleep quality in girls with primary dysmenorrhea.
Methods: For this purpose, 60 girls with moderate primary dysmenorrhea disorder (score 4-7) were randomly placed in 4 groups: resistance training + melatonin, resistance training + placebo, melatonin supplement group, and control group. Pain intensity, and sleep quality were assessed by the McGill questionnaire, and the Pittsburgh questionnaire respectively. 10 mg of melatonin was taken daily in two 5 mg capsules and the placebo group received the same amount of carbohydrates in the same capsule. Weight training, three days a week for eight weeks. This circuit exercise training was in 9 stations and with a maximum of 10-12 repetitions at 30-65% of a maximum repetition in each station. Each set and repetition was separated by 2-3 minutes and 90 seconds of rest, respectively. The blood sample was taken in the morning, fasting and 5 cc from the brachial vein from the left hand while sitting in the sitting position, and was taken by special kits. Data were analyzed by ANOVA with repeated measures and Bonferroni post hoc test at level P<0.05. All experimental procedures were approved by the Ethics committee of the Sport Sciences Research Institute of Iran (Code: ID IR.IAU.NEYSHABUR.REC.1401.008), Clinical Trial (Code: ID IRCT20230703058653N1) from the Iran Clinical Registration Center and were conducted under the Declaration of Helsinki.
Results: A significant increase in Estrogen (P<0.001) and progesterone (P<0.001) levels in the exercise + supplement group compared to all groups, and in the exercise + placebo group and the supplement group compared to the placebo group was reported. Also, The decrease in Pain intensity (P<0.001) and sleep quality (A decrease in the sleep score means an increase in the sleep quality in the output of the questionnaire) (P<0.001) in the supplement group compared to all groups and in the exercise + placebo group (P<0.05) and the exercise + supplement group compared to the placebo group showed a significant difference.
Conclusions: It seems that synergy of exercise and melatonin has affected the sex hormones level. Also, the melatonin probably helped to improve the sleep quality and pain intensity of the subjects through the adjustment of sex hormones following dysmenorrhea. Also, exercise probably has an effect on the pain intensity and sleep quality through the release of beta-endorphins and the effects of exercise on the menstrual cycle, although the finding are ambiguous.
